Table 2_Tracing microbial community across endophyte-to-saprotroph continuum of Cinnamomum camphora (L.) Presl leaves considering priority effect of endophyte on litter decompositi... by Jiamin Xiao (226355)

“…Both endogenous keystone and dominant taxa exerted significant potential influences on litter decomposition. …”

Table1_Ultra-Processed Food Consumption Among College Students and Their Association With Body Composition, Bowel Movements and Menstrual Cycle.docx by Anindita Ghosh (2892734)

“…Higher UPF consumption showed a trend toward increased body fat (p = 0.053) and was significantly associated with greater visceral fat accumulation (p < 0.05). …”

Table 2_Investigating the accuracy of Garmin PPG sensors on differing skin types based on the Fitzpatrick scale: cross-sectional comparison study.docx by Annie Icenhower (20945288)

“…Similarly, there was no significant main effect for the Fitzpatrick score, although there was a significant main effect for phase, which was driven by greater ECG-recorded heart rate relative to PPG during the first ramp-up phase.…”

Table 1_Investigating the accuracy of Garmin PPG sensors on differing skin types based on the Fitzpatrick scale: cross-sectional comparison study.docx by Annie Icenhower (20945288)

“…Similarly, there was no significant main effect for the Fitzpatrick score, although there was a significant main effect for phase, which was driven by greater ECG-recorded heart rate relative to PPG during the first ramp-up phase.…”

Supplementary Material for: Pharmacokinetic Properties of Dapagliflozin in Patients with Stage 4 Chronic Kidney Disease by figshare admin karger (2628495)

“…The pharmacokinetic data on dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, is limited in patients with severe renal impairment. …”

Table 3_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 9_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 1_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 2_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 13_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 6_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 7_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 12_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 11_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 10_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 14_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 8_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 5_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Table 4_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.csv by Chang Li (133800)

“…Similarly, the age-standardized prevalence rate also significantly increased from 498.49 (340.79, 686.31) to 588.46 (396.8, 816.79), with an estimated annual percentage change (EAPC) of 0.42% (0.4%, 0.44%). …”

Supplementary file 1_Global, regional, and national total burden related to hepatitis B and attributable risk factors in adults aged 65 years and older from 1990 to 2021 and projec... by Linying Gao (4379200)

“…ASIR and ASPR both showed significant decreasing trends in males and females, with persistently higher rates observed among males across all study years. …”